Fulcrum Therapeutics, Inc. (FULC) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $80.00M | +2752.0% |
| 2023 | $2.81M | -55.8% |
| 2022 | $6.34M | -66.9% |
| 2021 | $19.16M | +117.2% |
| 2020 | $8.82M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $80.00M | +2752.0% |
| 2023 | $2.81M | -55.8% |
| 2022 | $6.34M | -66.9% |
| 2021 | $19.16M | +117.2% |
| 2020 | $8.82M | — |